Moreover, the protection against NAFLD in ARMCX3-KO mice was accompanied by less HFD-induced alanine aminotransferase (ALT) activity in plasma (Figure 1G) indicating reduced hepatocellular injury [18]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.